ArticleMolecular cancer therapeutics2024

Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation.

Lily L Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.